Imatinib Use in Pregnancy
The outcome in patients with chronic myeloid leukemia (CML) has dramatically improved over the last decade due to the widespread use of novel tyrosine kinase inhibitors such as imatinib. As overall survival has improved, the number of women with CML that wish to become pregnant has increased. As suc...
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Galenos Publishing House
2012-12-01
|
| Reeks: | Turkish Journal of Hematology |
| Onderwerpen: | |
| Online toegang: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-82542 |